What is CareSyntax?
Founded in 2013, CareSyntax operates at the intersection of healthcare technology and risk management. The company's core mission is to enhance patient safety and operational efficiency in hospitals by transforming raw clinical data into actionable insights. Through its integrated solutions combining Internet of Things (IoT) devices and advanced data analytics, CareSyntax empowers surgical care providers to identify and reduce risks, thereby improving outcomes and streamlining healthcare delivery. The company's focus on data-driven risk reduction positions it as a key player in the evolving landscape of healthtech.
How much funding has CareSyntax raised?
CareSyntax has raised a total of $433.4M across 6 funding rounds:
Private Equity
$11.9M
Unspecified
$20M
Series B
$45.6M
Other Financing Round
$45.6M
Debt
$350K
Series C
$310M
Private Equity (2017): $11.9M with participation from Norgine
Unspecified (2018): $20M led by Surgical
Series B (2019): $45.6M, investors not publicly disclosed
Other Financing Round (2019): $45.6M featuring Mitsubishi Corporation, Whiz Partners, Relyens, Plug and Play, IPF Partners, and Barco Healthcare
Debt (2020): $350K backed by PPP
Series C (2024): $310M with participation from Vesalius Biocapital, Optum Ventures, Surgical.Ai, Symbiotic Capital, Intel Capital, Lauxera Capital Partners, Arno Capital Partners, Relyens Group, Plug and Play Tech Center, IPF Partners, PFM Health Sciences, and Rezayat Group
Key Investors in CareSyntax
Vesalius Biocapital
Vesalius Biocapital is a European venture capital investor focused on the life sciences sector, primarily investing in later-stage companies involved in drug development, medical devices, diagnostics, and eHealth/mHealth.
Optum Ventures
Optum Ventures invests in early-stage companies that are poised to disrupt the status quo in healthcare, aiming to make health care better for everyone.
Surgical.Ai
Surgical.ai is dedicated to transforming the surgical landscape by investing in and supporting innovative surgical companies, leveraging technology and artificial intelligence to enhance critical healthcare processes.
What's next for CareSyntax?
With its latest major strategic investment, CareSyntax is poised to accelerate its expansion and further develop its innovative risk-reduction technologies. The substantial capital infusion, particularly from strategic partners, suggests a focus on scaling operations, enhancing its data analytics capabilities, and potentially expanding its market reach. This funding will likely enable CareSyntax to deepen its impact on hospital safety and efficiency, solidifying its position as a leader in healthtech solutions for risk mitigation. Future growth may involve strategic partnerships and the integration of advanced AI to further refine its offerings.
See full CareSyntax company page
